Correlation Between Regeneron Pharmaceuticals and GB Sciences
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and GB Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and GB Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and GB Sciences, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and GB Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of GB Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and GB Sciences.
Diversification Opportunities for Regeneron Pharmaceuticals and GB Sciences
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Regeneron and GBLX is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and GB Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GB Sciences and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with GB Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GB Sciences has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and GB Sciences go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and GB Sciences
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the GB Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 27.57 times less risky than GB Sciences. The stock trades about -0.07 of its potential returns per unit of risk. The GB Sciences is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 0.42 in GB Sciences on December 28, 2024 and sell it today you would lose (0.39) from holding GB Sciences or give up 92.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 96.77% |
Values | Daily Returns |
Regeneron Pharmaceuticals vs. GB Sciences
Performance |
Timeline |
Regeneron Pharmaceuticals |
GB Sciences |
Regeneron Pharmaceuticals and GB Sciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regeneron Pharmaceuticals and GB Sciences
The main advantage of trading using opposite Regeneron Pharmaceuticals and GB Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, GB Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GB Sciences will offset losses from the drop in GB Sciences' long position.Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
GB Sciences vs. Antibe Therapeutics | GB Sciences vs. Awakn Life Sciences | GB Sciences vs. America Great Health | GB Sciences vs. Therasense |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |